Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Slides
Videos-PodcastsVideos & Podcasts

Quicksearch

N11: Development of a young person clinic for 16-24-year-olds with Inflammatory Bowel Disease (IBD), using a multidisciplinary team (MDT) approach.ECCO'22
Year: 2022
Authors: Hamzawi, M.(1);Hickey, Y.(1);Brannick, S.(1);Brett Kilmurray, O.(1);Jones, F.(1);Sheridan, J.(1);Cullen, G.(1);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;
N12: Systematic Review: The role of psychological stress in Inflammatory Bowel DiseaseECCO'22
Year: 2022
Authors: Black, J.(1);Sweeney, L.(1);Yuan, Y.(1);Singh, H.(2);Norton, C.(1);Czuber-Dochan, W.(1);
(1)King's College London, Florence Nightingale Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;(2)Study Advisory Group, n/a, London, United Kingdom;
N13: Clinical service delivery implications of the Covid-19 pandemic on people with inflammatory bowel disease: a qualitative studyECCO'22
Year: 2022
Authors: Kemp, K.(1);Avery, P.(2);Bryant, R.(3);Cross, A.(4);Danter, K.(3);Kneebone, A.(5);Morris, D.(6);Walker, A.(7);Whitley, L.(8);Dibley, L.(9);
(1)Manchester Royal Infirmary, Gastroenterology, Manchester, United Kingdom;(2)St Mark's Hospital- Harrow, IBD Unit, London, United Kingdom;(3)Patient and Public Involvement Colleague, x, x, United Kingdom;(4)Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom;(5)Royal Bolton Hospital, Gastroenterology, Bolton, United Kingdom;(6)Lister Hospital, Endoscopy, Stevenage, United Kingdom;(7)South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;
N14: Who can do it, if not me? - Identification of biopsychosocial predictors for the quality of life, satisfaction with life, and acceptance of the gastrointestinal diseaseECCO'22
Year: 2022
Authors: Rudnik, A.(1);Piotrowicz, G.(2);Piotrowicz, A.(3);Bidzan, M.(4);Rydzewska, G.(5);
(1)University of Gdansk, Institute of Psychology, Gdańsk, Poland;(2)Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology-, Gdańsk, Poland;(3)Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology, Gdańsk, Poland;(4)University of Gdańsk, Institute of Psychology, Gdańsk, Poland;(5)Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, Warsaw, Poland;
N15: Feedback from adolescents and parents on the transition process to an Irish Adult IBD serviceECCO'22
Year: 2022
Authors: Hamzawi, M.(1);Brannick, S.(1);Hickey, Y.(1);Jones, F.(1);Brett Kilmurray, O.(1);Sheridan, J.(1);Cullen, G.(1);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;
N16: ‘Same storm, different boat’… Exploring the impact of the COVID-19 pandemic on patients with Inflammatory Bowel Disease, with or without shielding: a qualitative studyECCO'22
Year: 2022
Authors: Kemp, K.(1);Avery, P.(2);Bryant, R.(3);Cross, A.(4);Danter, K.(3);Kneebone, A.(5);Morris, D.(6);Walker, A.(7);Whitley, L.(8);Dibley, L.(9);
(1)Manchester Royal Infirmary, Department of Gastroenterology, Manchester, United Kingdom;(2)St. Mark's Hospital, IBD Unit, London, United Kingdom;(3)Patient & Public Involvement Colleague, x, x, United Kingdom;(4)Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom;(5)Royal Bolton Hospital, Gastroenterology, Bolton, United Kingdom;(6)Lister Hospital, Endoscopy, Stevenage, United Kingdom;(7)South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;
N17: Co Design of young person’s IBD clinic for 16-24 year oldsECCO'22
Year: 2022
Authors: Hamzawi, M.(1);Brannick, S.(2);Hickey, Y.(2);Cullen, G.(2);Sheridan, J.(2);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;(2)St Vincent's University Hospital, Gastroenterology, Dublin, Ireland;
N18: Introduction of inflammatory bowel disease specialized dietitian and nutritional status in a multidisciplinary IBD teamECCO'22
Year: 2022
Authors: Hoekx, S.(1);Vanderstappen, J.(1);Wellens, J.(1);Verstockt, B.(1);Marc, F.(1);Vermeire, S.(1);Guedelha Sabino, J.(1);
(1)KU Leuven, Gastroenterology, Leuven, Belgium;
N19: Improving the standard of care for patients with IBD - translating the N-ECCO Consensus StatementsECCO'22
Year: 2022
Authors: Kjaer-Mikkelsen, E.(1);Hindhede, A.(2);Bager, P.(3);
(1)Regional Hospital West Jutland, Unit of Gastroenterology, Herning, Denmark;(2)Odense University Hospital, Medical Gastrointestinal Diseases, Odense, Denmark;(3)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus N, Denmark;
N20: Safety of extended blood monitoring for adult Inflammatory Bowel Disease (IBD) patients on oral azathioprine during the COVID-19 pandemic: a single-centre auditECCO'22
Year: 2022
Authors: AL-HASANI, A.(1);Younge, L.(1);Chana, A.(1);
(1)St Marks Hospital- London North West University Healthcare NHS Trust, Gastroenterology, London, United Kingdom;
OP01: Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)ECCO'22
Year: 2022
Authors: LouisJ, E.(1);Resche-Rigon, M.(2);Laharie, D.(3);Satsangi, J.(4);Ding, N.(5);Preiss, J.(6);d'haens, G.(7);picon, L.(8);bossuyt, P.(9);vuitton, L.(10);irving, P.(11);bouhnik, Y.(12);viennot, S.(13);lamb, C.(14);pollock, R.(15);baert, F.(16);nachury, M.(17);mathurin, F.(18);Gilletta, C.(19);colombel, J.F.(20);hertervig, E.(21);
(1)CHU Liège- Sart Tilman, Department of Gastroenterology, Liège, Belgium;(2)Inserm U1077, Biostatistics, Paris, France;(3)CHU Bordeaux, Gastroenterology, Bordeaux, France;(4)John Radcliffe hospital, Gastroenterology, Oxford, United Kingdom;(5)St Vincent Hospital Melbourne, Gastrtoenterology, Melbourne, Australia;(6)Charite Berlin, Gastroenterology, Berlin, Germany;(7)AMC Amsterdam, Gastroenterology, Amsterdam, The Netherlands;(8)CHU Tours, Gastroenterology, Tours, France;(9)Imelda Hospital, Gastroenterology, Bonheiden, Belgium;(10)CHU Besancon, Gastroenterology, Besancon, France;(11)London-Guy's and Thomas, Gastroenterology, London, United Kingdom;(12)Hôpital Beaujon, Gastroenterology, Paris, France;(13)CHU Caen, Gastroenterology, Caen, France;(14)Royal Victoria Infirmary, Gastroenterology, Newcastle, United Kingdom;(15)St Georges' University Hospital, Gastroenterology, London, United Kingdom;(16)AZ Delta, Gastroenterology, Roeselare, Belgium;(17)CHU Lille, Gastroenterology, Lille, France;(18)CHU Amiens, Gastroenterology, Amiens, France;(19)CHU Toulouse, Gastroenterology, Toulouse, France;(20)Mount Sinai Hopsital, Gastroenterolgy, New York, United States;(21)skane university hospital, gastroenterology, Lund, Sweden;
OP02: The breastmilk proteomics of women with Inflammatory Bowel Disease (IBD) and its impact on fecal calprotectin and microbiota composition in their babiesECCO'22
Year: 2022
Authors: Guedelha Sabino, J.(1);Tarassishin, L.(2);Agrawal, M.(3);Eisele, C.(2);Barré, A.(2);Dubinsky, M.(4);Stone, J.(5);Nair, N.(2);Debebe, A.(2);Hawkins, K.(2);Rendon, A.(2);Hu, J.(2);Colombel, J.F.(3);Peter, I.(2);Torres, J.(6);
(1)KU Leuven, Gastroenterology, Leuven, Belgium;(2)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States;(3)Icahn School of Medicine at Mount Sinai-, Division of Gastroenterology- Department of Medicine, New York, United States;(4)Icahn School of Medicine at Mount Sinai, Division of Pediatric Gastroenterology and Hepatology, New York, United States;(5)Icahn School of Medicine at Mount Sinai, Department of Obstetrics- Gynecology and Reproductive Sciences-, New York, United States;(6)Hospital Beatriz Ângelo, Gastroenterology Division, Loures, Portugal;
OP03: Standardized faecal microbiota transplantation with microbiome-guided donor selection in active UC patients: A randomized, placebo-controlled intervention studyECCO'22
Year: 2022
Authors: Caenepeel, C.(1,2);Deleu, S.(1);Arnauts, K.(1);Vazquez Castellanos, J.F.(3);Braekeleire, S.(1);Machiels, K.(1);Baert, F.(4);Mana, F.(5);Pouillon, L.(6);Hindryckx, P.(7);Lobaton, T.(7);Louis, E.(8);Franchimont, D.(9);Ferrante, M.(1,2);Sabino, J.(1,2);Vieira-Silva, S.(3);Falony, G.(3);Raes, J.(3);Vermeire, S.(1,2);
(1)KU Leuven, TARGID - Department of chronic diseases and metabolism, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(3)Rega institute, Department of Microbiology and Immunology, Leuven, Belgium;(4)AZ Delta Roeselare, Department of Gastroenterology and Hepatology, Roeselare, Belgium;(5)University Hospitals Brussel, Department of Gastroenterology and Hepatology, Brussel, Belgium;(6)Imelda Hospital Bonheiden, Department of Gastroenterology and Hepatology, Leuven, Belgium;(7)Ghent University Hospital, Department of Gastroenterology and Hepatology, Ghent, Belgium;(8)CHU Liège, Department of Gastroenterology and Hepatology, Liège, Belgium;(9)Erasmus Hospital Brussel, Department of Gastroenterology and Hepatology, Brussel, Belgium;
OP04: Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trialECCO'22
Year: 2022
Authors: Travis, S.(1);Silverberg, M.S.(2);Danese, S.(3);Gionchetti, P.(4);Löwenberg, M.(5);Jairath, V.(6,7);Feagan, B.G.(7);Bressler, B.(8);Lindner, D.(9);Escher, A.(9);Jones, S.(9);Shen, B.(10);
(1)John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom;(2)Mount Sinai Hospital Inflammatory Bowel Disease Centre, Division of Gastroenterology- Department of Medicine, Toronto, Canada;(3)IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(4)University of Bologna- S. Orsola- Malpighi Hospital, IBD Unit- Department of Medicine and Surgery DIMEC, Bologna, Italy;(5)Amsterdam University Medical Centre- Location Academic Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Western University, Department of Medicine- Division of Gastroenterology, London, Canada;(7)Alimentiv, Alimentiv, London, Canada;(8)University of British Columbia, Department of Medicine- Division of Gastroenterology, Vancouver, Canada;(9)Takeda Pharmaceuticals International, Takeda Pharmaceuticals International, Zurich, Switzerland;(10)Columbia University Irving Medical Center/Herbert Irving Pavilion, Columbia University Irving Medical Center/Herbert Irving Pavilion, New York, United States;
OP05: Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS studyECCO'22
Year: 2022
Authors: Shavit, Z.(1);Stein, R.(2);Aloi, M.(3);Ledder, O.(4);Focht, G.(4);Urlep, D.(5);Hyams, J.(6);Broide, E.(7);Vais, B.(8);Levine, J.(9);Shouval , D.(10);Matar, M.(10);Assa, A.(10);Rosh, J.(11);Hussey, S.(12);Markowitz, J.(13);Yerushalmy-Feler, A.(14);Miele, E.(15);Shaoul, R.(16);Russell, R.K.(17);Turner, D.(4);
(1)Shaare Zedek Medical Center, The Pediatric Gastroenterology and Nutrition Institute, Jerusalem, Israel;(2)Children’s Hospital of Philadelphia, Center for Pediatric Inflammatory Bowel Disease, Philadelphia, United States;(3)Sapienza University of Rome- Umberto I Hospital, Pediatric Gastroenterology and Liver Unit, Rome, Italy;(4)Shaare Zedek Medical Center- Jerusalem, The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Jerusalem, Israel;(5)University Children’s Hospital- Ljubljana, Pediatric Gastroenterology, Ljubljana, Slovenia;(6)Connecticut Children's Medical Center, Center for Digestive Diseases, Connecticut, United States;(7)Shamir Medical Center, Paediatric Gastroenterology and Nutrition, Beer Yaakov, Israel;(8)Sheba Medical Center, Pediatric Gastroenterology, Ramat Gan, Israel;(9)NYU Langone Health, Pediatric Gastroenterology, New York, United States;(10)Schneider Children’s Medical Center, The Institute of Gastroenterology- Nutrition and Liver Diseases, Petah Tikva, Israel;(11)Goryeb Children's Hospital/Atlantic Health, Pediatric Gastroenterology, New Jersey, United States;(12)Children’s Health Ireland- Crumlin, Pediatric Gastroenterology, Dublin, Ireland;(13)The Feinstein Institute for Medical Research, Pediatric Gastroenterology, Northwell, United States;(14)Tel Aviv Sourasky Medical Center, Pediatric Gastroenterology- Liver and Nutrition, Tel Aviv, Israel;(15)University of Naples Frederico II, Pediatric Gastroenterology, Naples, Italy;(16)Rambam Medical Center, Pediatric Gastroenterology Unit, Haifa, Israel;(17)The Royal Hospital for Children & Young People, Pediatric Gastroenterology and Nutrition, Edinburgh, United Kingdom;
OP06: The influence of different prednisolone tapering algorithms on the effectiveness of infliximab in patients with Ulcerative Colitis – A real-world cohort studyECCO'22
Year: 2022
Authors: Ovesen, P.D.(1);Ilvemark, J.F.K.F.(1);Attauabi, M.(1);Seidelin, J.B.(1);
(1)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;
OP07: Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trialECCO'22
Year: 2022
Authors: Schreiber, S.(1);Feagan, B.(2,3);Peyrin-Biroulet, L.(4);Vermeire, S.(5);Faes, M.(6);Harris, K.(7);Oortwijn, A.(7);Daniele, P.(8);Patel, H.(6);Danese, S.(9,10);
(1)Kiel University, Department of General Internal Medicine, Kiel, Germany;(2)Alimentiv, Inc., London, Canada;(3)London Health Sciences Centre- Western- Western University, Division of Gastroenterology, London, Canada;(4)University Hospital of Nancy- University of Lorraine, Department of Gastroenterology, Vandoeuvre-lès-Nancy, France;(5)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(6)Galapagos, Nv, Mechelen, Belgium;(7)Galapagos, Nv, Leiden, The Netherlands;(8)Cytel Health, Canada, Toronto, Canada;(9)University Vita-Salute, San Raffaele, Milan, Italy;(10)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;
OP08: The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance resultsECCO'22
Year: 2022
Authors: Danese, S.(1);Tran, J.(2);D'Haens, G.(3);Rubin, D.T.(4);Aoyama, N.(5);Zhou, W.(2);James, B.(2);Yao, X.(2);SanchezGonzalez, Y.(2);Panaccione, R.(6);
(1)Gastroenterology and Endoscopy IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, n/a, Milano, Italy;(2)AbbVie Inc., n/a, North Chicago, United States;(3)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(4)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;(5)Aoyama Medical Clinic, Department of Gastroenterology- Gastrointestinal Endoscopy and IBD Center, Kobe, Japan;(6)University of Calgary, Department of Gastroenterology and Hepatology, Calgary, Canada;
OP09: Proactive Therapeutic Drug Monitoring is superior to standard treatment during maintenance therapy with infliximab; results from a 52-week multicentre randomised trial of 450 patients; the NOR-DRUM B studyECCO'22
Year: 2022
Authors: Jørgensen, K.K.(1);Syversen, S.W.(2);Goll, G.L.(2); Bjørlykke, K.H.(1,3);Sandanger, Ø.(4);Sexton, J.(2);Brun, M.K.(2,3);Noraberg, G.(5);Ystrøm, C.M.(6); Seeberg, K.A.(7);Blomgren, I.M.(8);Torp, R.(9);Mørk, C.(10);Kvien, T.K.(2,3); Bolstad , N.(4);Haavardsholm, E.A.(2,3);Jahnsen, J.(1,3); The NOR-DRUM study group
(1)Akershus University Hospital, Dept. of Gastroenterology, Oslo, Norway;(2)Diakonhjemmet Hospital, Division of Rheumatology and Research, Oslo, Norway;(3)University of Oslo, Faculty of Medicine, Oslo, Norway;(4)Oslo University Hospital, Section of Dermatology, Oslo, Norway;(5)Hospital of Southern Norway Trust, Dept. of Gastroenterology, Arendal, Norway;(6)Innlandet Hospital Trust, Dept. of Medicine, Elverum, Norway;(7)Vestfold Hospital Trust, Dept. of Gastroenterology, Tønsberg, Norway;(8)Fonna Hospital Trust, Dept. of Gastroenterology, Haugesund, Norway;(9)Innlandet Hospital Trust, Dept. of Medicine, Hamar, Norway;(10)Akershus Dermatology Center, Dept. of Dermatology, Lørenskog, Norway;
OP10: Comparative efficacy of biologics for endoscopic healing of the ileum and colon in Crohn’s DiseaseECCO'22
Year: 2022
Authors: Narula, N.(1);Wong, E.(1);Dulai, P.(2);Marshall, J.(1);Jairath, V.(3);Reinisch, W.(4);
(1)McMaster University, Department of Medicine Division of Gastroenterology, Hamilton, Canada;(2)University of California San Diego, Division of Gastroenterology, La Jolla, United States;(3)Western University, Department of Medicine Division of Gastroenterology, London, Canada;(4)Medical University of Vienna, Department of Internal Medicine III Division of Gastroenterology and Hepatology, Vienna, Austria;